Spring 2027 Clinical Trial Intern
Medpace, Inc.
Summary
Our clinical operations activities are growing rapidly, and we are currently seeking a full or part-time, office-based Clinical Trial Intern to join our Clinical Operations team. This internship will provide you with insight on the day-to-day responsibilities of a Project Coordinator. You will receive hands-on training and support various clinical trial management projects. We are seeking intern candidates who are wishing to pursue a career in Clinical Research, with the ability to work during the Spring 2027 semester.
Job description
Responsibilities
- Provide day-to-day project support activities - maintenance of project-related files, corresponding with study teams, etc.
- Perform administrative duties in conformity with company policies and procedures.
- Coordinate and schedule meetings, provide meeting minutes.
- Maintain databases/project specific status reports.
- Support filing and quality control reviews of our internal regulatory filing system.
- Manage study supplies.
- Perform other administrative tasks as needed.
Qualifications
- Working towards a Bachelor's degree in a Life Science field with graduation date in Spring/Fall 2027.
- Excellent organizational, communication, and prioritization skills.
- Knowledge of Microsoft Office.
- Availability to work a minimum of 20 hours per week in our Cincinnati, OH office.
Requirements
- Working towards a Bachelor's degree in a Life Science field with graduation date in Spring/Fall 2027
- Excellent organizational, communication, and prioritization skills
- Knowledge of Microsoft Office
- Availability to work a minimum of 20 hours per week in our Cincinnati, OH office
Benefits
- Competitive compensation
- Health insurance
- Wellness programs
- Retirement benefits
- Paid time off
- On-site fitness facilities
- On-site dining options
- Free on-site parking
Company overview
Medpace Holdings, Inc. is a global full-service clinical contract research organization (CRO) headquartered in Cincinnati, Ohio, founded in 1992. The company provides comprehensive Phase I-IV clinical development services to biotechnology, pharmaceutical, and medical device industries worldwide. With over 30 years of experience, Medpace employs a scientifically-driven approach that integrates medical, operational, and regulatory expertise across all major therapeutic areas including oncology, cardiology, metabolic diseases, endocrinology, central nervous system disorders, and infectious diseases. The company operates a unique full-service model that includes wholly-owned central laboratories, bioanalytical laboratories, imaging core labs, ECG core labs, and a Phase I clinical unit, all integrated to streamline clinical trial execution. Medpace's global presence spans North America, Europe, Asia Pacific, and Latin America, with approximately 6,000 employees across 44 countries. The company went public in 2016 and trades on NASDAQ under the symbol MEDP, consistently demonstrating strong growth while maintaining its focus on accelerating the development of safe and effective medical therapeutics through high-quality clinical research services.